X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA LUPIN LTD SHASUN PHARMA/
LUPIN LTD
 
P/E (TTM) x 123.9 22.3 554.7% View Chart
P/BV x 8.5 3.0 281.9% View Chart
Dividend Yield % 0.2 0.8 28.2%  

Financials

 SHASUN PHARMA   LUPIN LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
LUPIN LTD
Mar-17
SHASUN PHARMA/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs941,750 5.4%   
Low Rs461,384 3.3%   
Sales per share (Unadj.) Rs214.2387.4 55.3%  
Earnings per share (Unadj.) Rs5.356.6 9.4%  
Cash flow per share (Unadj.) Rs15.876.8 20.6%  
Dividends per share (Unadj.) Rs1.007.50 13.3%  
Dividend yield (eoy) %1.40.5 298.9%  
Book value per share (Unadj.) Rs53.3298.9 17.8%  
Shares outstanding (eoy) m56.62451.58 12.5%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x0.34.0 8.1%   
Avg P/E ratio x13.127.7 47.4%  
P/CF ratio (eoy) x4.420.4 21.7%  
Price / Book Value ratio x1.35.2 25.0%  
Dividend payout %18.713.2 141.5%   
Avg Mkt Cap Rs m3,958707,513 0.6%   
No. of employees `000NA16.8 0.0%   
Total wages/salary Rs m2,16428,495 7.6%   
Avg. sales/employee Rs ThNM10,418.3-  
Avg. wages/employee Rs ThNM1,697.0-  
Avg. net profit/employee Rs ThNM1,523.0-  
INCOME DATA
Net Sales Rs m12,127174,943 6.9%  
Other income Rs m2291,065 21.5%   
Total revenues Rs m12,356176,008 7.0%   
Gross profit Rs m1,00944,931 2.2%  
Depreciation Rs m5949,122 6.5%   
Interest Rs m4151,525 27.2%   
Profit before tax Rs m23035,349 0.6%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 -0.4%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-739,785 -0.7%   
Profit after tax Rs m30225,575 1.2%  
Gross profit margin %8.325.7 32.4%  
Effective tax rate %-31.727.7 -114.4%   
Net profit margin %2.514.6 17.0%  
BALANCE SHEET DATA
Current assets Rs m6,884119,542 5.8%   
Current liabilities Rs m8,45661,206 13.8%   
Net working cap to sales %-13.033.3 -38.9%  
Current ratio x0.82.0 41.7%  
Inventory Days Days6276 81.1%  
Debtors Days Days10890 119.7%  
Net fixed assets Rs m4,970131,660 3.8%   
Share capital Rs m113903 12.5%   
"Free" reserves Rs m2,875134,073 2.1%   
Net worth Rs m3,020134,976 2.2%   
Long term debt Rs m1,81756,478 3.2%   
Total assets Rs m13,347266,073 5.0%  
Interest coverage x1.624.2 6.4%   
Debt to equity ratio x0.60.4 143.8%  
Sales to assets ratio x0.90.7 138.2%   
Return on assets %5.410.2 52.8%  
Return on equity %10.018.9 52.8%  
Return on capital %13.319.3 69.2%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84381,885 7.1%   
Fx outflow Rs m2,17321,506 10.1%   
Net fx Rs m3,66960,378 6.1%   
CASH FLOW
From Operations Rs m39841,148 1.0%  
From Investments Rs m-1,635-25,287 6.5%  
From Financial Activity Rs m1,3094,332 30.2%  
Net Cashflow Rs m7120,193 0.4%  

Share Holding

Indian Promoters % 39.2 46.6 84.1%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 3.6 11.3 31.9%  
FIIs % 17.6 31.9 55.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 10.1 392.1%  
Shareholders   20,750 98,259 21.1%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   STRIDES SHASUN LTD  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare SHASUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Trade Flat; TCS Surges 3.5%(01:30 pm)

Indian share markets continued to trade on a flat note in the noon session. Gains are largely seen in software stocks, bank stocks and capital goods' stocks.

Related Views on News

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS